APVO
Aptevo Therapeutics Inc
NASDAQ: APVO · HEALTHCARE · BIOTECHNOLOGY
$4.81
-1.94% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2.70x
EPS (TTM)
$-87.27
Dividend yield
—
52W range
$4 – $189
Volume
0.1M
Aptevo Therapeutics Inc (APVO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-51.39M | $-47.01M | $-48.76M | $-36.86M | $-41.57M | $-51.42M | $-42.38M | $-29.32M | $-21.68M | $-21.02M | $-11.73M | $-23.79M | $-25.59M |
| Capital expenditures | $1.02M | $989000.00 | $1.53M | $2.51M | $1.40M | $976000.00 | $153000.00 | $88000.00 | $713000.00 | $29000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | $666000.00 | $2.02M | $2.91M | $3.36M | $3.13M | $2.39M | $2.23M | $1.31M | $1.14M | $901000.00 | $567000.00 | $352000.00 | — |
| Stock-based comp | $955000.00 | $1.07M | $1.11M | $3.81M | $4.88M | $2.14M | $1.60M | $1.25M | $1.64M | $1.80M | $2.19M | $1.07M | $96000.00 |
| Free cash flow | $-52.41M | $-48.00M | $-50.29M | $-39.37M | $-42.98M | $-52.40M | $-42.54M | $-29.41M | $-22.39M | $-21.05M | $-11.73M | $-23.79M | $-25.59M |
| Investing cash flow | $-1.02M | $-48.80M | $-1.53M | $-47.39M | $29.46M | $72.80M | $4.10M | $28.03M | $-713000.00 | $-29000.00 | — | — | — |
| Financing cash flow | $52.41M | $99.40M | $51.33M | $89.30M | $9.53M | $-787000.00 | $20.15M | $23.87M | $26.16M | $-2.62M | $6.00M | $15.60M | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | — | $58000.00 | $21.25M | $10.23M | $4000.00 | — | — | $1.57M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $5.04M | $-2.58M | $20.59M | $-18.14M | — | — | — | — | — | — |